Plain-English translation of NCT05890716 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The WILLEM trial is testing a cloud-based artificial intelligence software called Willem™ that analyzes heart electrical tracings (ECGs) to detect heart rhythm abnormalities and heart diseases. Researchers will compare the AI software's diagnoses with diagnoses made by cardiologists to see how accurate the software is. The study aims to understand whether this technology can help doctors quickly identify and predict heart problems in patients admitted to the hospital.
Heart rhythm problems and heart diseases can be life-threatening, and doctors need fast, accurate ways to diagnose them. This trial exists to see whether artificial intelligence can read heart tracings as well as cardiologists can, which could help identify problems earlier and improve patient care.
You likely qualify if…
You likely don't qualify if…
As a participant, you would share your heart electrical tracings (ECGs) that were already recorded as part of your hospital care — the study uses existing medical records and devices. You will be placed into either a training group (to help develop the AI software) or a testing group (to evaluate how well it works). There are no additional visits or procedures required beyond what you're already receiving for your heart condition.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
Netherlands
Spain